5-Aminosalicylate Use and Colorectal Cancer Risk in Inflammatory Bowel Disease: A Large Epidemiological Study

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Yearbook of Gastroenterology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0739-5930(08)70326-X
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• 5-Aminosalicylate use and colorectal cancer risk in inflammatory bowel disease: a large epidemiological study

  2005cited by this paper

• Chrysin ameliorates dextran sulfate-induced ulcerative colitis in mice by modulating inflammation and gut microbiota

  2025cites this paper
• Acute Administration of Ojeok-san Ameliorates Pain-like Behaviors in Pre-Clinical Models of Inflammatory Bowel Diseases

  2023cites this paper
• Risk factors for the postoperative recurrence of ulcerative colitis-associated colorectal cancer

  2023cites this paper
• Effects of Cheonggukjang (Fermented Soybean) on the Development of Colitis-Associated Colorectal Cancer in Mice

  2023cites this paper
• Colorectal Cancer in Ulcerative Colitis: Mechanisms, Surveillance and Chemoprevention

  2022cites this paper
• Questionnaire survey to identify meal habits which influence adherence to oral 5‐aminosalicylic acid regimens in patients with ulcerative colitis

  2021cites this paper
• Depression in individuals who subsequently develop inflammatory bowel disease: a population-based nested case–control study

  2020cites this paper
• The impact of smoking and smoking cessation on disease outcomes in ulcerative colitis: a nationwide population‐based study

  2019cites this paper
• Smoking Status at Diagnosis and Subsequent Smoking Cessation: Associations With Corticosteroid Use and Intestinal Resection in Crohn's Disease

  2018cites this paper
• Reduced Risk of Inflammatory Bowel Disease-associated Colorectal Neoplasia with Use of Thiopurines: a Systematic Review and Meta-analysis

  2018cites this paper
• Systematic review with meta‐analysis: use of 5‐aminosalicylates and risk of colorectal neoplasia in patients with inflammatory bowel disease

  2017cites this paper
• Adherence to systemic therapies for immune-mediated inflammatory diseases in Lebanon: a physicians’ survey from three medical specialties

  2017cites this paper
• Prevention of Colitis and Colitis-Associated Colorectal Cancer by a Novel Polypharmacological Histone Deacetylase Inhibitor

  2016cites this paper
• Chemopreventive effects of 5-aminosalicylic acid on inflammatory bowel disease-associated colorectal cancer and dysplasia: a systematic review with meta-analysis

  2016cites this paper
• Colitis-associated colon cancer: Is it in your genes?

  2015cites this paper
• Peroxisome proliferator-activated receptor-γ is downregulated in ulcerative colitis and is involved in experimental colitis-associated neoplasia.

  2015cites this paper
• Intestinal Tumorigenesis

  2015cites this paper
• Colon Cancer Screening and Surveillance in Inflammatory Bowel Disease

  2014cites this paper
• [Chemoprevention of colorectal cancer in inflammatory bowel disease].

  2014cites this paper
• 5-Aminosalicylates Reduce the Risk of Colorectal Neoplasia in Patients with Ulcerative Colitis: An Updated Meta-Analysis

  2014cites this paper
• Colorectal cancer in inflammatory bowel disease: results of the 3rd ECCO pathogenesis scientific workshop (I).

  2014cites this paper
• Chemoprevention of Colorectal Cancer

  2014cites this paper
• Dysplasia and colorectal cancer in a patient with ulcerative colitis and primary sclerosing cholangitis: a case report and a short review of the literature.

  2013cites this paper
• Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations.

  2013cites this paper
• Colorectal Cancer in Ulcerative Colitis Patients

  2012cites this paper
• Age at diagnosis of inflammatory bowel disease influences early development of colorectal cancer in inflammatory bowel disease patients: a nationwide, long-term survey

  2012cites this paper
• 5-Aminosalicylate Is Not Chemoprophylactic for Colorectal Cancer in IBD: A Population Based Study

  2011cites this paper
• Pathogenesis and biomarkers of carcinogenesis in ulcerative colitis

  2011cites this paper
• Risk of Cancer in Inflammatory Bowel Disease Treated With Azathioprine: A UK Population-Based Case–Control Study

  2010cites this paper
• Targeting NF-κB for colorectal cancer

  2010cites this paper
• Chemoprophylaxis in colorectal cancer: current concepts and a practical algorithm for use

  2010cites this paper
• Factors that modify therapy adherence in patients with inflammatory bowel disease.

  2010cites this paper
• Ulcerative Colitis Practice Guidelines in Adults: American College of Gastroenterology, Practice Parameters Committee

  2010cites this paper
• Inflammatory Bowel Disease as a Risk Factor for Colorectal Cancer

  2010cites this paper
• Factors thatmodify therapy adherence in patients with inflammatory bowel disease ☆

  2010cites this paper
• Colon cancer in infl ammatory bowel disease : recent trends , questions and answers Cancer

  2009cites this paper
• Cancer risks in Crohn disease patients.

  2009cites this paper
• [Treatment adherence in inflammatory bowel disease. Strategies for improvement].

  2009cites this paper
• Cost Effectiveness of Ulcerative Colitis Surveillance in the Setting of 5-Aminosalicylates

  2009cites this paper
• Systematic review: does concurrent therapy with 5‐ASA and immunomodulators in inflammatory bowel disease improve outcomes?

  2009cites this paper
• Recent advances in inflammatory bowel disease

  2009cites this paper
• Chrysin, a natural flavone, improves murine inflammatory bowel diseases.

  2009cites this paper
• The long journey of salicylates in ulcerative colitis: The past and the future.

  2009cites this paper
• European evidence-based Consensus on the management of ulcerative colitis: Special situations.

  2008cites this paper
• 5-ASA Treatment for Ulcerative Colitis: What’s on the Horizon?

  2008cites this paper
• 5‐Aminosalicylic acid (mesalazine) use in Crohn's disease: A survey of the opinions and practice of Australian gastroenterologists

  2007cites this paper
• The Risk of Cancer in Patients with Crohn’s Disease

  2007cites this paper
• Current World Literature

  2007cites this paper
• HETEs enhance IL-1-mediated COX-2 expression via augmentation of message stability in human colonic myofibroblasts.

  2007cites this paper
• The role of mesalamine in the treatment of ulcerative colitis

  2007cites this paper
• Prevention of Colorectal Cancer in Inflammatory Bowel Disease: Value of Screening and 5-Aminosalicylates

  2006cites this paper
• Review article: mode of action and delivery of 5‐aminosalicylic acid – new evidence

  2006cites this paper
• Systematic review: the use of mesalazine in inflammatory bowel disease

  2006cites this paper
• Update in the treatment of paediatric ulcerative colitis

  2006cites this paper
• ORIGINAL RESEARCH A Nucleotide Analog Prevents Colitis-Associated Cancer via Beta-Catenin Independently of In fl ammation and Autophagy

  year unknowncites this paper